Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReckitt Regulatory News (RKT)

Share Price Information for Reckitt (RKT)

Share Price is delayed by 15 minutes
Get Live Data
4,648.00    108.00 (2.38%)
Bid:
4,623.00
Ask:
4,625.00
Spread: 2.00 (0.043%)
Market Cap: £29.56b
RKT Live PriceLast checked at - London Stock Exchange

Intraday Reckitt Share Chart

CEO Transition

1 Sep 2023 07:00

RNS Number : 0317L
Reckitt Benckiser Group PLC
01 September 2023
 

 

1 September 2023

RECKITT BENCKISER GROUP PLC (the 'Company')

 

Kris Licht to take over as CEO of Reckitt on 1 October 2023

 

Further to the Company's announcement on 26 April 2023, Reckitt today confirms that Kris Licht will assume the role of Chief Executive Officer on 1 October 2023, succeeding Nicandro Durante. Nicandro will stay with Reckitt until 31 December 2023 to ensure a smooth transition, at which time he will step down from the Board.

 

Details of Kris Licht's remuneration arrangements in connection with his appointment as CEO were set out in the RNS announcement of his appointment on 26 April 2023. Details of Nicandro Durante's remuneration arrangements in connection with his departure are set out in the Section 430(2B) Companies Act 2006 Statement which is available in the Corporate Governance section of the Company website.

 

 

Contacts

Richard Joyce & Hazel Chung +44 (0)7807 418516 / +44 (0)7408 850537

Investor Relations

 

Patty O'Hayer +44 (0)7825 755688

External Relations and Government Affairs

 

FGS Global

Faeth Birch +44 (0)7768 943171

 

 

About Reckitt:

Reckitt* exists to protect, heal and nurture in the relentless pursuit of a cleaner, healthier world. We believe that access to the highest-quality hygiene, wellness and nourishment is a right, not a privilege. 

 

Reckitt is the company behind some of the world's most recognisable and trusted consumer brands in hygiene, health and nutrition, including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, Woolite and more. 

 

Every day, more than 30 million Reckitt products are bought globally. We always put consumers and people first, seek out new opportunities, strive for excellence in all that we do and build shared success with all our partners. We aim to do the right thing, always. 

 

We are a diverse global team of c. 40,000 colleagues. We draw on our collective energy to meet our ambitions of purpose-led brands, a healthier planet and a fairer society. Find out more, or get in touch with us at www.reckitt.com 

 

* Reckitt is the trading name of the Reckitt Benckiser group of companies 

 

Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFLFLATDILVIV
Date   Source Headline
5th Sep 20257:00 amRNSTransaction in Own Shares
4th Sep 20257:00 amRNSTransaction in Own Shares
3rd Sep 20257:00 amRNSTransaction in Own Shares
2nd Sep 20257:00 amRNSTransaction in Own Shares
1st Sep 20253:50 pmRNSTotal Voting Rights
1st Sep 20258:48 amRNSEMTN Programme: publication of Base Prospectus
1st Sep 20257:00 amRNSTransaction in Own Shares
29th Aug 20257:00 amRNSTransaction in Own Shares
28th Aug 20257:00 amRNSTransaction in Own Shares
27th Aug 20257:00 amRNSTransaction in Own Shares
26th Aug 20253:14 pmRNSReplacement – Transaction in Own Shares
26th Aug 20257:00 amRNSTransaction in Own Shares
22nd Aug 20257:00 amRNSTransaction in Own Shares
21st Aug 20257:00 amRNSTransaction in Own Shares
20th Aug 20257:00 amRNSTransaction in Own Shares
19th Aug 20257:00 amRNSTransaction in Own Shares
18th Aug 20257:00 amRNSTransaction in Own Shares
15th Aug 20257:00 amRNSTransaction in Own Shares
14th Aug 20257:00 amRNSTransaction in Own Shares
13th Aug 20257:00 amRNSTransaction in Own Shares
12th Aug 20257:00 amRNSTransaction in Own Shares
11th Aug 20257:00 amRNSTransaction in Own Shares
8th Aug 20257:00 amRNSTransaction in Own Shares
7th Aug 20257:00 amRNSTransaction in Own Shares
6th Aug 20257:00 amRNSTransaction in Own Shares
5th Aug 20257:00 amRNSTransaction in Own Shares
4th Aug 20257:00 amRNSTransaction in Own Shares
1st Aug 20253:33 pmRNSTotal Voting Rights
1st Aug 202512:30 pmRNSDirector/PDMR Shareholding
1st Aug 20257:00 amRNSTransaction in Own Shares
31st Jul 202511:00 amRNSDirector/PDMR Shareholding
31st Jul 20257:00 amRNSTransaction in Own Shares
30th Jul 20254:08 pmRNSDirector/PDMR Shareholding
30th Jul 20257:00 amRNSTransaction in Own Shares
29th Jul 20257:00 amRNSTransaction in Own Shares
28th Jul 20257:00 amRNS2025 SHARE BUYBACK PROGRAMME – FIRST TRANCHE
25th Jul 20258:00 amRNSDirectorate Change
24th Jul 20257:00 amRNSRESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2025
18th Jul 20257:00 amRNSRECKITT AGREES TO DIVEST ESSENTIAL HOME
1st Jul 202511:50 amRNSTotal Voting Rights
1st Jul 20257:02 amRNSCOMPLETION OF SHARE BUYBACK PROGRAMME
1st Jul 20257:00 amRNSTransaction in Own Shares
30th Jun 20257:00 amRNSTransaction in Own Shares
27th Jun 20257:00 amRNSTransaction in Own Shares
26th Jun 20257:00 amRNSTransaction in Own Shares
25th Jun 20257:00 amRNSTransaction in Own Shares
24th Jun 20257:00 amRNSTransaction in Own Shares
23rd Jun 20257:00 amRNSTransaction in Own Shares
20th Jun 20257:00 amRNSTransaction in Own Shares
19th Jun 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.